QUALCOMM (NASDAQ:QCOM) has been given an average rating of “Buy” by the thirty-three ratings firms that are presently covering the company, AnalystRatings.Net reports. Twelve equities research analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the company. QUALCOMM, Inc. (NASDAQ:QCOM) belongs to Technology sector. Its net profit margin is 30.10% and weekly performance is -8.95%. On last trading day company shares ended up $70.29. QUALCOMM, Inc. (NASDAQ:QCOM) distance from 50-day simple moving average (SMA50) is -5.78%. Citigroup Inc. (NYSE:C) said it will pay $1.02 billion to settle a probe by regulators for failing to stop traders from trying to manipulate the foreign exchange market. Citigroup Inc. (NYSE:C) shares moved down -0.72% in last trading session and ended the day at $53.42. C return on assets is 0.50%. Citigroup Inc. (NYSE:C) quarterly performance is 8.75%. Trans World Entertainment (NASDAQ:TWMC) major shareholder Lloyd I. Miller III bought 77,460 shares of Trans World Entertainment stock on the open market in a transaction that occurred on Tuesday, November 11th. The shares were purchased at an average cost of $3.19 per share, for a total transaction of $247,097.40. On 12 November, Trans World Entertainment Corporation (NASDAQ:TWMC) shares remains unchanged and was closed at $3.18. TWMC EPS growth in last 5 year was 16.10%. Trans World Entertainment Corporation (NASDAQ:TWMC) year to date (YTD) performance is -19.08%. LGI Homes, Inc. (NASDAQ:LGIH) announced results for the third quarter 2014 and the nine months ended September 30, 2014. Diluted EPS of $0.34 on Net Income of $7.0 million, Net Income Before Income Taxes Increased 31.8% to $10.5 million. LGI Homes, Inc. (NASDAQ:LGIH) ended the last trading day at $18.54. Company weekly volatility is calculated as 5.13% and price to cash ratio as 8.97. LGI Homes, Inc. (NASDAQ:LGIH) showed a weekly performance of -3.84%. Goldman Sachs upgraded its rating on shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Monday morning to "Buy" from "Neutral." BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) shares advanced 0.96% in last trading session and ended the day at $86.95. BMRN Gross Margin is 83.70% and its return on assets is -5.40%. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) quarterly performance is 28.49%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
